Home » Clinical development » AIR-NET: Testing anti-inflammatories for the treatment of bronchiectasis
AIR-NET: Testing anti-inflammatories for the treatment of bronchiectasis

Research area:

Chronic & rare respiratory

Disease:

Bronchiectasis

Intervention:

Therapeutics – Small molecules

Phase:

Phase II

Funding awarded to

University of Dundee

Public registration details (where available)

ISRCTN17596258

Visit this trial’s project page

Related news

Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

Read more: Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments

MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

Read more: MRC Technology invests £7 million to expand its diagnostics research capability in Scotland

UK Drug Discovery Consortium symposium

Read more: UK Drug Discovery Consortium symposium